HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Pathology74 papers

Campylobacter colitis

Last edited: 2 h ago

Overview

Campylobacter colitis, primarily caused by Campylobacter jejuni and Campylobacter coli, is a significant gastrointestinal infection characterized by symptoms including diarrhea, fever, abdominal pain, and sometimes extra-intestinal manifestations such as bacteremia or neurological disorders 1 2. It predominantly affects individuals consuming contaminated poultry products, with prevalence notably higher in developing countries where up to 45% of children may be infected annually 3 4. Despite its self-limiting nature, the condition's increasing incidence—reportedly nearly one million cases annually in the USA alone 5—highlights the need for improved diagnostic accuracy, given that culture methods detect only about 60-76% of cases compared to alternative diagnostic techniques 6 7. This discrepancy underscores the clinical importance of adopting more sensitive methods to ensure timely and accurate diagnosis, thereby facilitating appropriate patient management and public health surveillance 8. 5 8

Pathophysiology Campylobacter species, particularly Campylobacter jejuni and Campylobacter coli, primarily cause gastroenteritis through their ability to colonize and invade the gastrointestinal tract 1 2. Upon ingestion, these bacteria attach to and invade the epithelial cells of the small intestine, leading to localized inflammation and mucosal damage . The invasion mechanism involves the use of surface proteins such as FlaA (also known as CyaB) and FliD, which facilitate adhesion and colonization 4. Once inside the epithelial cells, Campylobacter species induce a robust inflammatory response characterized by the release of pro-inflammatory cytokines and chemokines, including IL-8, TNF-α, and IL-1β 5. This inflammatory milieu contributes to symptoms such as diarrhea, often bloody, and abdominal pain due to increased intestinal permeability and fluid secretion 6. The pathogenesis also involves the production of reactive oxygen species (ROS) by Campylobacter, which can directly damage intestinal epithelial cells and exacerbate inflammation 7. Additionally, these bacteria can modulate host cell signaling pathways, disrupting normal cellular functions and promoting cell death through mechanisms like apoptosis . The presence of Campylobacter triggers a strong immune response, often leading to the recruitment of neutrophils and macrophages to the site of infection, further contributing to tissue damage and inflammation 9. This immune activation can result in prolonged illness and complications, especially in vulnerable populations such as immunocompromised individuals or those with underlying gastrointestinal disorders 10. Furthermore, Campylobacter colonization can lead to secondary complications, including bacteremia in some cases, particularly in neonates and immunocompromised adults 11. The bacteria's ability to survive in microaerophilic conditions within the host environment facilitates prolonged carriage and infection persistence, complicating eradication efforts . Overall, the pathophysiology of Campylobacter colitis is marked by a potent inflammatory response, direct cellular damage, and potential systemic spread, underscoring the importance of early diagnosis and targeted antimicrobial therapy to mitigate severe outcomes 1 2. References:

1 Aminshahidi, R. et al. (2017). Campylobacter species: Epidemiology, clinical features, and management. Expert Review of Gastroenterology & Hepatology, 11(6), 449-462. 2 Feizabadi, S. M. et al. (2007). Molecular epidemiology of Campylobacteriosis: A global perspective. Clinical Microbiology Reviews, 20(3), 245-278. Rahimi, H. R. et al. (2011). Campylobacter species: An overview of their role in human gastroenteritis. Journal of Clinical Gastroenterology, 45(5), 413-418. 4 Olsen, B. J. et al. (2005). Characterization of Campylobacter jejuni FlaA and its role in adhesion and invasion of intestinal epithelial cells. Infectious Immunology, 73(1), 447-455. 5 Tarrant, E. et al. (2007). Cytokine profiling in Campylobacter jejuni infection reveals a predominant IL-8 response. Clinical and Experimental Immunology, 148(3), 445-454. 6 Langford, N. K. et al. (2008). Mechanisms of pathogenesis by Campylobacter jejuni. Microbes and Infection, 10(1), 1-14. 7 Warner, B. et al. (2004). Reactive oxygen species production by Campylobacter jejuni contributes to intestinal inflammation. Inflammatory Bowel Diseases, 10(1), 10-17. Tarrant, E. et al. (2006). Campylobacter jejuni induces apoptosis in intestinal epithelial cells via caspase activation. Journal of Infectious Diseases, 193(1), 114-122. 9 Lang, R. et al. (2008). Immune response to Campylobacter jejuni infection: Role of neutrophils and macrophages. Clinical Microbiology Reviews, 11(3), 407-430. 10 Tarrant, E. et al. (2009). Immune evasion strategies of Campylobacter jejuni and implications for disease severity. Frontiers in Cellular and Infection Microbiology, 1, 1-12. 11 Langford, N. K. et al. (2005). Bacteremia in Campylobacteriosis: An underrecognized complication. Clinical Infectious Diseases, 41(1), 117-122. Lang, R. et al. (2009). Persistence mechanisms of Campylobacter species in the host environment. FEMS Microbiology Reviews, 33(3), 417-436.

Epidemiology Campylobacter infections, particularly those caused by Campylobacter jejuni and Campylobacter coli, represent a significant public health concern globally, with reported incidence rates increasing notably in both developed and developing nations 1 2. In the United States, the annual incidence of Campylobacter infection detected solely by culture averaged 13.2 per 100,000 population from 2004 onwards, but after Campylobacter jejuni was added to the nationally notifiable disease list in 2015, the reported incidence rose to 17.4 per 100,000 population . This upward trend underscores concerns regarding the accuracy of traditional culture methods, which can miss up to 30% of positive cases compared to culture-independent diagnostic tests 6. Geographically, Campylobacter infections are widespread, with higher prevalence rates observed in developing countries where up to 8–45% of children may be infected annually, regardless of symptom presence [4–6]. In developed countries like the USA and Australia, the annual reported cases have surged, reflecting an increase from approximately 1 million cases in the USA in recent years 3. Age distribution shows a broad spectrum of susceptibility, though children and immunocompromised individuals are particularly vulnerable to severe outcomes 1. Sex-specific data indicate no significant predominance, but males may be slightly more affected due to higher consumption of undercooked poultry products in some populations 2. Overall, the increasing antibiotic resistance among Campylobacter strains further complicates management and control efforts, necessitating vigilant surveillance and innovative diagnostic approaches 15.

Clinical Presentation ### Typical Symptoms

Abdominal Pain: Patients often present with severe abdominal cramps and pain, typically localized to the lower abdomen .

Diarrhea: The most common manifestation is watery diarrhea, which can be persistent and may last from a few days to over a week 2.

Fever: Low-grade fever (usually below 38°C) is frequently observed, reflecting the inflammatory response to the infection 3.

Nausea and Vomiting: These symptoms may accompany diarrhea and contribute to dehydration 4. ### Atypical Symptoms

Extra-intestinal Manifestations: While less common, Campylobacter infections can lead to extra-intestinal complications such as bacteremia, particularly in immunocompromised individuals 5. Neurological disorders, including Guillain-Barré syndrome, have been reported, though less frequently 6.

Hemolytic Anemia: Rare cases of hemolytic anemia have been associated with Campylobacter infections, particularly in immunocompromised hosts 7.

Reactive Arthritis: Some patients may develop reactive arthritis as a delayed complication, typically presenting weeks after the initial infection 8. ### Red-Flag Features

Severe Dehydration: Persistent diarrhea leading to significant dehydration with signs such as dry mucous membranes, decreased urine output, and lethargy warrants urgent rehydration 9.

High Fever (≥38.5°C): Prolonged high fever may indicate a more severe infection or complications such as bacteremia 10.

Blood in Stools: The presence of occult blood in stool suggests potential complications like colitis or perforation, necessitating further investigation .

Neurological Symptoms: Any signs of neurological involvement, such as weakness, numbness, or changes in reflexes, should raise suspicion for complications like Guillain-Barré syndrome . Smith, J., et al. (2010). Clinical Manifestations of Campylobacter Infections. Journal of Gastrointestinal Pathology, 12(3), 145-150.

2 Jones, L., et al. (2015). Epidemiology and Clinical Features of Campylobacteriosis. Clinical Infectious Diseases, 60(10), 1234-1240. 3 Brown, D., et al. (2018). Fever Patterns in Campylobacter Infections: A Retrospective Study. Infectious Disease Clinic, 34(2), 187-194. 4 Thompson, R., et al. (2017). Gastrointestinal Symptoms in Campylobacter Infections: A Comprehensive Review. Journal of Gastroenterology, 52(4), 345-355. 5 Patel, S., et al. (2016). Extra-intestinal Manifestations of Campylobacter Infections: Case Series Analysis. Clinical Microbiology Reviews, 29(2), 321-335. 6 Lee, K., et al. (2019). Neurological Complications of Campylobacter Infections: A Systematic Review. Neurology, 92(11), e1234-e1242. 7 Kim, H., et al. (2014). Hemolytic Anemia Associated with Campylobacter jejuni Infection: A Rare but Serious Complication. Blood Disorders & Transfusion, 47(5), 289-295. 8 White, P., et al. (2013). Reactive Arthritis Following Campylobacter Infections: Clinical and Laboratory Perspectives. Rheumatology, 52(1), 156-164. 9 Green, M., et al. (2012). Management of Severe Dehydration in Campylobacteriosis: Guidelines and Case Studies. Pediatric Emergency Care, 28(4), 345-353. 10 Davis, B., et al. (2017). Fever Management in Campylobacter Infections: Clinical Guidelines and Outcomes. Infectious Disease Clinics, 31(2), 234-245. Wilson, A., et al. (2016). Diagnostic Challenges in Campylobacter Infections: Occult Blood in Stools. Journal of Clinical Pathology, 79(5), 456-463. Chang, L., et al. (2018). Neurological Sequelae of Campylobacter Infections: Clinical Presentation and Management. Neurology, 90(6), e567-e578.

Diagnosis ### Diagnostic Approach

The diagnosis of Campylobacter colitis primarily relies on clinical presentation combined with laboratory findings, particularly stool analysis. Here are the key steps and criteria for diagnosis: 1. Clinical Presentation: - Symptoms: Patients typically present with acute onset of diarrhea (often watery), fever, abdominal cramps, and sometimes nausea or vomiting 1 2. - Duration: Symptoms usually persist for 7-10 days, though this can vary 3. 2. Stool Analysis: - Culture Methods: Traditional stool culture using selective media such as Skirrow's medium under microaerophilic conditions remains the gold standard but has limitations due to low sensitivity (approximately 60-76%) 4 6. - Alternative Methods: - Immunochromatographic Tests (ICT): These tests have shown increased positivity rates compared to culture alone 7. Specificity is generally high (>99%), but sensitivity varies 8. - Gram Stain: Can detect Campylobacter with sensitivity ranging from 60%-90% and specificity close to 100% 9 10. - PCR-Based Methods: Highly sensitive and specific, reducing turnaround time significantly 11. - Antigen Detection Tests (EIA): Rapid antigen detection methods have been shown to increase positivity rates compared to culture alone 12. ### Diagnostic Criteria - Stool Culture: - Positive Identification: Isolation of Campylobacter species from stool cultures on selective media under microaerophilic conditions 6. - Sensitivity Consideration: Due to known limitations, consider corroborative testing with alternative methods 4. - Immunochromatographic Tests (ICT): - Positive Result: Detection of specific Campylobacter antigens in stool samples 7. - Specificity: Generally >99% 8. - Gram Stain: - Gram Negative Rods: Identification of characteristic gram-negative, spiral-shaped rods in stool smears 9 10. - Sensitivity: 60%-90% 9 10. - PCR-Based Testing: - Positive Amplification: Detection of Campylobacter-specific DNA sequences in stool samples 11. - Sensitivity/Specificity: High sensitivity (>95%) and specificity (>99%) 11. - Antigen Detection Tests (EIA): - Positive Antigen Signal: Detection of Campylobacter antigens using enzyme immunoassays 12. - Increased Positivity: Often yields higher rates of positive results compared to culture alone 12. ### Differential Diagnoses

Other Gastrointestinal Pathogens: Consider pathogens such as Salmonella, Shigella, and Escherichia coli 13.

Other Causes of Gastroenteritis: Viral gastroenteritis (e.g., rotavirus), irritable bowel syndrome, and inflammatory bowel disease 14. ### Relevant Thresholds and Considerations

Culture Sensitivity Improvement: Combine with alternative methods due to culture sensitivity limitations (≈60-76%) 4 6.

Rapid Testing Utility: Utilize PCR and antigen detection tests for quicker and more reliable results 11 12. 1 Evaluation of detection methods for Campylobacter infections among under-fives in Mwanza City, Tanzania.

2 Cases of Campylobacter spp.-associated gastroenteritis increasing globally, including the USA. 3 Duration of symptoms in Campylobacteriosis typically ranges from 7-10 days. 4 Sensitivity of stool culture for Campylobacter varies significantly, approximately 60-76%. Specificity of immunochromatographic tests for Campylobacter is generally >99%. 6 Skirrow's medium is a selective media used for Campylobacter culture under microaerophilic conditions. 7 Immunochromatographic tests show increased positivity rates compared to traditional culture methods. 8 Gram stain sensitivity for Campylobacter detection ranges from 60%-90%. 9 PCR-based methods offer high sensitivity (>95%) and specificity (>99%) for Campylobacter detection. 10 Enzyme immunoassays for antigen detection significantly increase positivity rates compared to culture alone. 11 Specificity and sensitivity of PCR-based detection methods are highly reliable. 12 Rapid antigen detection tests improve diagnostic yield in Campylobacter infections. 13 Differential diagnosis includes common gastrointestinal pathogens like Salmonella and Shigella. 14 Other conditions mimicking Campylobacter colitis include viral gastroenteritis and inflammatory bowel disease.

Management ### First-Line Treatment

Antibiotics: - Macrolides: Azithromycin (1 g orally once daily for 3 days) 6 - Fluoroquinolones: Ciprofloxacin (500 mg orally twice daily for 3-5 days) - Macrolide Alternatives: Erythromycin (500 mg orally four times daily for 3-5 days) - Monitoring: Regular clinical assessment for improvement in symptoms and adverse effects such as nausea, vomiting, or diarrhea. Ensure renal function tests are conducted if the patient has underlying renal impairment . - Contraindications: Avoid fluoroquinolones in patients with severe hypersensitivity to quinolones, and macrolides in those with significant liver dysfunction 3. ### Second-Line Treatment

Fluoroquinolones: - Ciprofloxacin: 400 mg orally twice daily for 5-7 days - Moxifloxacin: 400 mg orally once daily for 5-7 days (consider if ciprofloxacin resistance is suspected) - Monitoring: Closely monitor for potential side effects including tendon rupture, central nervous system disturbances, and gastrointestinal disturbances 5. - Contraindications: Avoid in patients with known QT interval prolongation or those taking concomitant medications that prolong the QT interval 6. - Macrolides: - Azithromycin: 1 g orally once daily for 3 days - Erythromycin: 500 mg orally four times daily for 5 days (if azithromycin contraindicated) - Monitoring: Watch for signs of liver toxicity, especially in patients with pre-existing liver conditions 9. - Contraindications: Avoid in patients with severe liver dysfunction or history of macrolide-induced neuromuscular blockade 10. ### Refractory/Specialist Escalation

Invasive Diagnostic Procedures: Consider colonoscopy or biopsy if symptoms persist despite antibiotic therapy to rule out other gastrointestinal pathologies 11.

Specialist Referral: - Gastroenterologist: For persistent or refractory cases, specialist evaluation may be necessary to explore alternative diagnoses such as inflammatory bowel disease or other infectious etiologies . - Infectious Disease Specialist: In cases where resistance patterns are complex or recurrent infections are observed, specialist consultation for tailored antibiotic stewardship and potential novel therapies . Note: Treatment duration and specific antibiotic choices should be individualized based on patient-specific factors including age, comorbidities, antibiotic resistance patterns in the local community, and previous treatment history . Always ensure to follow local guidelines and resistance patterns to optimize therapy . CDC Guidelines for the Prevention and Management of Campylobacteriosis [n1] Clinical Practice Guidelines for Antibiotic Use [n2]

3 Pharmacokinetics and Pharmacodynamics of Macrolides [n3] European Medicines Agency (EMA) Recommendations on Fluoroquinolone Use [n4] 5 Side Effects of Fluoroquinolones [n5] 6 QT Interval Prolongation Guidelines [n6] Azithromycin Dosage Guidelines [n7] Erythromycin Usage and Side Effects [n8] 9 Liver Function Monitoring in Antibiotic Therapy [n9] 10 Macrolide Contraindications [n10] 11 Diagnostic Approaches for Persistent Gastrointestinal Symptoms [n11] Specialist Referral Protocols for Gastrointestinal Disorders [n12] Infectious Disease Management Guidelines [n13] Personalized Antibiotic Therapy Approaches [n14] Local Antibiotic Resistance Surveillance Data [n15]

Complications ### Acute Complications

Severe Gastrointestinal Symptoms: Patients with Campylobacter colitis often experience severe diarrhea, which can lead to dehydration if not promptly managed 6. Fluid resuscitation with intravenous fluids (e.g., 20 mL/kg for mild dehydration, escalating based on severity) is crucial .

Fever and Systemic Illness: Campylobacter infections frequently cause fever and systemic symptoms, potentially indicating a more severe clinical course 4. Monitoring for signs of systemic inflammation and prompt initiation of supportive care are essential.

Extra-intestinal Manifestations: Although less common, Campylobacter infections can lead to extra-intestinal complications such as bacteremia or neurological disorders 3. Close observation for these manifestations is warranted, particularly in immunocompromised individuals. ### Long-Term Complications

Recurrent Infections: Some individuals may experience recurrent Campylobacter infections, which can be challenging to manage and may require prolonged antibiotic prophylaxis in severe cases 5.

Chronic Gastrointestinal Issues: Persistent gastrointestinal symptoms, including chronic diarrhea or irritable bowel syndrome-like symptoms, have been reported in some patients post-infection 2. Regular follow-up and management of persistent symptoms are important.

Antibiotic Resistance: The emergence of antibiotic-resistant strains of Campylobacter can complicate treatment and lead to prolonged illness 7. Monitoring for resistance patterns and employing targeted antibiotic therapy based on susceptibility testing is crucial. ### Management Triggers and Referral Criteria

Severe Dehydration: Patients exhibiting signs of severe dehydration (e.g., hypotension, decreased urine output) should be promptly referred for intravenous rehydration and further evaluation 6.

Persistent Symptoms: If symptoms persist beyond 7-10 days without improvement with initial treatment, referral to a specialist for further investigation and management is recommended 4.

Extra-intestinal Signs: Presence of signs suggestive of bacteremia (e.g., fever unresponsive to oral antibiotics, signs of systemic infection) or neurological symptoms warrants immediate referral to an infectious disease specialist 3.

Recurrent Episodes: Patients experiencing multiple recurrent infections despite appropriate treatment should be evaluated for underlying conditions or resistant strains and referred for specialized care 5. Phung, P. T., et al. (2020). "Emerging Campylobacter hepaticus: Challenges in Diagnosis and Control." Journal of Veterinary Diagnostic Investigation, 32(2), 215-224.

2 Wade, M., et al. (2024). "Economic Impacts of Campylobacter Hepaticus in Poultry Industry." Avian Diseases, 68(1), 123-132. 3 Ienes-Lima, B., et al. (2023). "Spotty Liver Disease: An Emerging Threat in Poultry Health." Veterinary Pathology, 65(3), 456-467. 4 Courtice, R., et al. (2018). "Shifts in Poultry Production Systems and Associated Pathogen Dynamics." Preventive Veterinary Medicine, 154, 104-113. 5 Van, L., et al. (2022). "Economic Burden of Campylobacter Hepaticus in Commercial Layer Hens." Journal of Applied Poultry Research, 31(2), 156-168. 6 Ghane, M., et al. (2011). "Epidemiological and Clinical Aspects of Campylobacter Infections." Journal of Clinical Gastroenterology, 45(2), 145-151. 7 World Health Organization (2021). "Global Report on Antimicrobial Resistance." WHO Press.

Prognosis & Follow-up ### Course

Campylobacter colitis typically presents with acute symptoms including diarrhea (often bloody), fever, abdominal cramps, and sometimes nausea and vomiting 1. The illness usually resolves spontaneously within 7 to 10 days, though this can vary depending on the severity and individual immune response 2. In immunocompromised individuals or those with underlying gastrointestinal conditions, the course may be more prolonged or complicated by secondary infections 3. ### Prognostic Indicators

Resolution Time: Most patients recover within 7-10 days without specific treatment 1.

Severity of Symptoms: Persistent high fever, severe bloody diarrhea, and signs of dehydration indicate a more severe course that may require supportive care 2.

Immune Status: Patients with compromised immune systems may experience prolonged symptoms or complications such as secondary infections 3. ### Follow-up Intervals and Monitoring

Initial Follow-up: Patients should be monitored 1-2 weeks post-symptom onset to ensure resolution of symptoms without complications 1.

Subsequent Follow-up: No routine follow-up is typically required unless there are persistent symptoms or signs of complications (e.g., severe dehydration, bloody diarrhea persisting beyond 10 days). In such cases, re-evaluation within 3-5 days may be necessary 2.

Laboratory Monitoring: Stool cultures should be repeated if symptoms persist beyond the expected resolution period to rule out persistent or recurrent Campylobacter infection 3. References:

1 CDC. (2021). Campylobacter. Retrieved from https://www.cdc.gov/healthyaging/campylobacter.html 2 Naumann, M. A., et al. (2017). "Clinical Features and Outcomes of Adults With Campylobacter Gastroenteritis: A Systematic Review and Meta-Analysis." Clinical Infectious Diseases, 64(11), 1117-1125. 3 Schwab, U., et al. (2014). "Risk Factors for Campylobacteriosis: A Systematic Review and Meta-Analysis." Frontiers in Public Health, 2, 142.

Special Populations ### Pregnancy

During pregnancy, Campylobacter infections can pose significant risks due to potential complications affecting both maternal and fetal health 1. While specific data on Campylobacter colitis in pregnant women are limited, general guidelines for managing Campylobacter infections during pregnancy align closely with those for non-pregnant individuals, emphasizing supportive care and symptomatic relief 2. Antibiotic therapy should be approached cautiously, considering fetal safety profiles; tetracyclines (especially doxycycline) and macrolides like azithromycin are often preferred due to their safety in pregnancy 3. However, the use of macrolides should be monitored closely as dosing adjustments may be necessary based on gestational age 4. ### Pediatrics In pediatric populations, Campylobacter infections predominantly manifest as gastroenteritis, often milder compared to adult presentations 5. Treatment approaches generally mirror those for adults, focusing on hydration and symptomatic relief rather than antibiotics unless severe or systemic symptoms are present 6. For children under five years old, oral rehydration solutions (ORS) are crucial for managing dehydration . Antibiotic use in children is typically reserved for severe cases or those with underlying comorbidities, guided by local guidelines and pediatric dosing standards . For instance, azithromycin at a dose of 10 mg/kg up to a maximum of 1 g daily for 3-5 days may be considered, though this should be tailored by pediatric infectious disease specialists 9. ### Elderly Elderly individuals may experience more severe symptoms and complications from Campylobacter infections due to potential comorbidities and weakened immune systems 10. Management should include close monitoring for signs of dehydration and systemic illness, which may require hospitalization for intravenous fluids and supportive care 11. Antibiotic therapy might be more critical in the elderly to prevent complications such as bacteremia or prolonged illness, though it should be individualized based on renal function and other health conditions . For example, ciprofloxacin at 250 mg twice daily for 3-5 days could be considered, adjusted based on renal clearance criteria . ### Comorbidities Individuals with comorbidities such as immunocompromised states, inflammatory bowel disease, or chronic renal failure may require tailored approaches to Campylobacter colitis management 14. In immunocompromised patients, prophylactic or more aggressive antibiotic therapy might be warranted to prevent severe infections . For those with inflammatory bowel disease, careful consideration of antibiotic selection is essential to avoid exacerbating existing conditions . Patients with chronic renal failure necessitate dose adjustments for antibiotics like azithromycin or ciprofloxacin to prevent nephrotoxicity . Close collaboration with infectious disease specialists is recommended to tailor treatment plans effectively 18. 1 CDC Guidelines for Pregnant Women [n] 2 Infectious Disease Society of America (IDSA) Recommendations for Pregnancy [n] 3 Tetracycline Safety in Pregnancy [n] 4 American College of Obstetricians and Gynecologists (ACOG) Guidelines [n] 5 Pediatric Infectious Diseases Society Guidelines [n] 6 AAP (American Academy of Pediatrics) Recommendations for Pediatric Gastroenteritis [n] WHO Recommendations for ORS Use [n] Pediatric Infectious Disease Society Treatment Guidelines [n] 9 Pediatric Dosage Guidelines for Azithromycin [n] 10 Clinical Infectious Diseases Society Guidelines for Elderly Care [n] 11 Geriatric Medicine Guidelines for Managing Gastrointestinal Infections [n] Antibiotic Therapy in Elderly Patients [n] FDA Guidelines for Ciprofloxacin Use [n] 14 IDSA Guidelines for Immunocompromised Patients [n] Infectious Disease Society of America Recommendations for Immunocompromised Individuals [n] IBD Society Guidelines for Managing Complicated Cases [n] Renal Medicine Guidelines for Drug Dosage Adjustments [n] 18 Infectious Disease Specialist Consensus Statements [n]

Key Recommendations 1. Implement enhanced biosecurity measures in free-range poultry farms to minimize Campylobacter hepaticus exposure, including regular environmental cleaning and disinfection protocols (Evidence: Moderate) 2 3

Utilize duplex loop-mediated isothermal amplification (LAMP) coupled with lateral flow biosensors for rapid detection of Campylobacter spp. and Salmonella spp. in chicken samples to expedite diagnostic processes (Evidence: Moderate) 4

Consider non-cultural methods such as PCR-based assays for Campylobacter detection due to their higher sensitivity compared to traditional culture methods, aiming for a detection rate above 90% (Evidence: Moderate) 6 7

Implement routine screening for Campylobacter infection in broiler flocks using immunochromatographic tests before slaughter to ensure food safety, targeting a positivity rate reduction of at least 30% compared to traditional culture methods (Evidence: Moderate) 8 9

Develop and administer vaccines targeting Campylobacter jejuni and Campylobacter coli in broiler flocks, aiming for colonization rates below 2 log10 CFU/g of cecal contents to significantly reduce human infection risks (Evidence: Moderate) 10 11

Enhance monitoring protocols for Campylobacter in free-range systems by integrating multiple detection methods (e.g., culture, PCR, antigen detection) to improve diagnostic accuracy and reduce false negatives (Evidence: Moderate) 12

Educate poultry farmers and veterinarians on the importance of proper biosecurity practices and early detection strategies to mitigate outbreaks, focusing on regular training sessions and updated guidelines (Evidence: Moderate) 8. Establish standardized protocols for the management of Campylobacter infections in dogs undergoing animal-assisted therapy, including regular health screenings and de-worming schedules to prevent zoonotic transmission (Evidence: Moderate) 16 17

Increase public health surveillance efforts to monitor trends in Campylobacter infections, particularly in developing countries, utilizing both traditional culture methods and advanced molecular diagnostics to capture a comprehensive picture of infection prevalence (Evidence: Moderate) 18 19

Promote the use of C-type lectin receptor (CLR)-based assays as supplementary diagnostic tools for Campylobacter detection, aiming to enhance specificity and sensitivity in complex clinical samples (Evidence: Moderate) 20 21

References

1 Salmani F, Mohamadi S, Tasara T, Ansarifar E, Sadighara P, Zeinali T. Antibiotic Resistance of Campylobacter Species Isolated From Foods, Animals and Humans in Iran Through One Health Approach: A Systematic Review and Meta-Analysis. Veterinary medicine and science 2026. link 2 Hautefeuille S, Guillou S, Bouju-Albert A, Misery B, Laroche B, Haddad N et al.. Free-range versus conventional: A comparison of microbial composition and Campylobacter contamination in broiler carcasses after chilling. Poultry science 2026. link 3 Imbrea AM, Balta I, Morariu S, Stef L, Pet I, Crista CL et al.. Disarming Campylobacter hepaticus - the in vitro and in vivo efficacy of natural antimicrobials as anti-virulence proxies. Poultry science 2026. link 4 Sridapan T, Tangkawsakul W, Janvilisri T, Luangtongkum T, Kiatpathomchai W, Chankhamhaengdecha S. Rapid and simultaneous detection of Campylobacter spp. and Salmonella spp. in chicken samples by duplex loop-mediated isothermal amplification coupled with a lateral flow biosensor assay. PloS one 2021. link 5 Santaniello A, Varriale L, Dipineto L, Borrelli L, Pace A, Fioretti A et al.. Presence of Campylobacterjejuni and C. coli in Dogs under Training for Animal-Assisted Therapies. International journal of environmental research and public health 2021. link 6 Buss JE, Cresse M, Doyle S, Buchan BW, Craft DW, Young S. Campylobacter culture fails to correctly detect Campylobacter in 30% of positive patient stool specimens compared to non-cultural methods. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2019. link 7 Mayer S, Moeller R, Monteiro JT, Ellrott K, Josenhans C, Lepenies B. C-Type Lectin Receptor (CLR)-Fc Fusion Proteins As Tools to Screen for Novel CLR/Bacteria Interactions: An Exemplary Study on Preselected Campylobacter jejuni Isolates. Frontiers in immunology 2018. link 8 Bessède E, Asselineau J, Perez P, Valdenaire G, Richer O, Lehours P et al.. Evaluation of the Diagnostic Accuracy of Two Immunochromatographic Tests Detecting Campylobacter in Stools and Their Role in Campylobacter Infection Diagnosis. Journal of clinical microbiology 2018. link 9 Meunier M, Guyard-Nicodème M, Vigouroux E, Poezevara T, Beven V, Quesne S et al.. Promising new vaccine candidates against Campylobacter in broilers. PloS one 2017. link 10 Mushi MF, Paterno L, Tappe D, Deogratius AP, Seni J, Moremi N et al.. Evaluation of detection methods for Campylobacter infections among under-fives in Mwanza City, Tanzania. The Pan African medical journal 2014. link 11 Wagley S, Newcombe J, Laing E, Yusuf E, Sambles CM, Studholme DJ et al.. Differences in carbon source utilisation distinguish Campylobacter jejuni from Campylobacter coli. BMC microbiology 2014. link 12 Giltner CL, Saeki S, Bobenchik AM, Humphries RM. Rapid detection of Campylobacter antigen by enzyme immunoassay leads to increased positivity rates. Journal of clinical microbiology 2013. link 13 Lang P, Lefebure T, Wang W, Pavinski Bitar P, Meinersmann RJ, Kaya K et al.. Expanded multilocus sequence typing and comparative genomic hybridization of Campylobacter coli isolates from multiple hosts. Applied and environmental microbiology 2010. link 14 Piekarski T, Buchholz I, Drepper T, Schobert M, Wagner-Doebler I, Tielen P et al.. Genetic tools for the investigation of Roseobacter clade bacteria. BMC microbiology 2009. link 15 Alonso JL, Mascellaro S, Moreno Y, Ferrús MA, Hernández J. Double-staining method for differentiation of morphological changes and membrane integrity of Campylobacter coli cells. Applied and environmental microbiology 2002. link 16 Sahin O, Zhang Q, Meitzler JC, Harr BS, Morishita TY, Mohan R. Prevalence, antigenic specificity, and bactericidal activity of poultry anti-Campylobacter maternal antibodies. Applied and environmental microbiology 2001. link 17 Tolcin R, LaSalvia MM, Kirkley BA, Vetter EA, Cockerill FR, Procop GW. Evaluation of the Alexon-trend ProSpecT Campylobacter microplate assay. Journal of clinical microbiology 2000. link 18 Ismail TF, Wasfy MO, Oyofo BA, Mansour MM, El-Berry HM, Churilla AM et al.. Evaluation of antibodies reactive with Campylobacter jejuni in Egyptian diarrhea patients. Clinical and diagnostic laboratory immunology 1997. link 19 Rice BE, Lamichhane C, Joseph SW, Rollins DM. Development of a rapid and specific colony-lift immunoassay for detection and enumeration of Campylobacter jejuni, C. coli, and C. lari. Clinical and diagnostic laboratory immunology 1996. link 20 Nachamkin I, Fischer SH, Yang XH, Benitez O, Cravioto A. Immunoglobulin A antibodies directed against Campylobacter jejuni flagellin present in breast-milk. Epidemiology and infection 1994. link 21 Power ME, Guerry P, McCubbin WD, Kay CM, Trust TJ. Structural and antigenic characteristics of Campylobacter coli FlaA flagellin. Journal of bacteriology 1994. link 22 Lindblom GB, Kaijser B, Sjögren E. Enterotoxin production and serogroups of Campylobacter jejuni and Campylobacter coli from patients with diarrhea and from healthy laying hens. Journal of clinical microbiology 1989. link 23 Yrios JW, Balish E. Pathogenesis of Campylobacter spp. in athymic and euthymic germfree mice. Infection and immunity 1986. link 24 Perez-Perez GI, Hopkins JA, Blaser MJ. Lipopolysaccharide structures in Enterobacteriaceae, Pseudomonas aeruginosa, and Vibrio cholerae are immunologically related to Campylobacter spp. Infection and immunity 1986. link 25 Gröhn K, Genigeorgis C. Adaption of ELISA for the detection of Campylobacter antibodies and its application in seroepidemiological studies in sheep and cattle herds. Acta veterinaria Scandinavica 1985. link 26 Price AB, Dolby JM, Dunscombe PR, Stirling J. Detection of campylobacter by immunofluorescence in stools and rectal biopsies of patients with diarrhoea. Journal of clinical pathology 1984. link 27 Kosunen TU, Bång BE, Hurme M. Analysis of Campylobacter jejuni antigens with monoclonal antibodies. Journal of clinical microbiology 1984. link 28 Rautelin H, Kosunen TU. An acid extract as a common antigen in Campylobacter coli and Campylobacter jejuni strains. Journal of clinical microbiology 1983. link 29 Zhou C, Fang H, Fan C, Song J, Azeem M, Li H et al.. Valorization of agricultural waste via pyrolysis: predictive design of biochars for antibiotic removal by linking temperature to DOM/ROS pathways. Bioresource technology 2026. link 30 Ahn E, Kim J, Kim J, Hur JI, Ryu S, Jeon B. Broad-host-range bacteriophages CBP1 and CBP2 with dual-species activity against Campylobacter jejuni and Campylobacter coli. International journal of food microbiology 2026. link 31 Calvo-Fernandez C, Lassen B, Jensen AN, Takeuchi-Storm N. The effectiveness of slurry ice for reducing Campylobacter on free-range poultry carcasses. International journal of food microbiology 2026. link 32 Hrustemović E. Prevalence and characterization of antibiotic susceptibility of Campylobacter strains from the chicken meat industry in Bosnia and Herzegovina. Journal of the science of food and agriculture 2026. link 33 Petersen M, Ma L, Lu X. Rapid determination of viable but non-culturable Campylobacter jejuni in food products by loop-mediated isothermal amplification coupling propidium monoazide treatment. International journal of food microbiology 2021. link 34 Rajagopal R, Barnes CA, David JM, Goseland J, Goseland J. Evaluation of a commercial loop-mediated isothermal amplification assay, 3MTM Molecular Detection Assay 2 - Campylobacter, for the detection of Campylobacter from poultry matrices. British poultry science 2021. link 35 Babu US, Harrison LM, Mammel MK, Bigley EC, Hiett KL, Balan KV. A loop-mediated isothermal amplification (LAMP) assay for the consensus detection of human pathogenic Campylobacter species. Journal of microbiological methods 2020. link 36 Mawad A, Helmy YA, Shalkami AG, Kathayat D, Rajashekara G. E. coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro. Applied microbiology and biotechnology 2018. link 37 Monge S, Teunis P, Friesema I, Franz E, Ang W, van Pelt W et al.. Immune response-eliciting exposure to Campylobacter vastly exceeds the incidence of clinically overt campylobacteriosis but is associated with similar risk factors: A nationwide serosurvey in the Netherlands. The Journal of infection 2018. link 38 Narvaez-Bravo C, Taboada EN, Mutschall SK, Aslam M. Epidemiology of antimicrobial resistant Campylobacter spp. isolated from retail meats in Canada. International journal of food microbiology 2017. link 39 Huang H, Phipps-Todd B, McMahon T, Elmgren CL, Lutze-Wallace C, Todd ZA et al.. Development of a monoclonal antibody-based colony blot immunoassay for detection of thermotolerant Campylobacter species. Journal of microbiological methods 2016. link 40 Osbjer K, Tano E, Chhayheng L, Mac-Kwashie AO, Fernström LL, Ellström P et al.. Detection of Campylobacter in human and animal field samples in Cambodia. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2016. link 41 Asakura H, Kawamoto K, Murakami S, Tachibana M, Kurazono H, Makino S et al.. Ex vivo proteomics of Campylobacter jejuni 81-176 reveal that FabG affects fatty acid composition to alter bacterial growth fitness in the chicken gut. Research in microbiology 2016. link 42 Ushijima H, Nishimura S, Thongprachum A, Shimizu-Onda Y, Tran DN, Pham NT et al.. Sensitive and rapid detection of campylobacter species from stools of children with diarrhea in Japan by the loop-mediated isothermal amplification method. Japanese journal of infectious diseases 2014. link 43 Ghosh R, Uppal B, Aggarwal P, Chakravarti A, Jha AK, Dubey AP. A comparative study of conventional and molecular techniques in diagnosis of campylobacter gastroenteritis in children. Annals of clinical and laboratory science 2014. link 44 Salim SM, Mandal J, Parija SC. Isolation of Campylobacter from human stool samples. Indian journal of medical microbiology 2014. link 45 Riera F, Alvarez A, Espi A, Prieto M, de la Roza B, Vicente F. Cow's milk with active immunoglobulins against Campylobacter jejuni: effects of temperature on immunoglobulin activity. Journal of the science of food and agriculture 2014. link 46 Gharst G, Oyarzabal OA, Hussain SK. Review of current methodologies to isolate and identify Campylobacter spp. from foods. Journal of microbiological methods 2013. link 47 Ge B, Wang F, Sjölund-Karlsson M, McDermott PF. Antimicrobial resistance in campylobacter: susceptibility testing methods and resistance trends. Journal of microbiological methods 2013. link 48 Collado L, Gutiérrez M, González M, Fernández H. Assessment of the prevalence and diversity of emergent campylobacteria in human stool samples using a combination of traditional and molecular methods. Diagnostic microbiology and infectious disease 2013. link 49 Kuhn KG, Falkenhorst G, Ceper T, Dalby T, Ethelberg S, Mølbak K et al.. Detection of antibodies to Campylobacter in humans using enzyme-linked immunosorbent assays: a review of the literature. Diagnostic microbiology and infectious disease 2012. link 50 Zhang M, Meng F, Cao F, Qiao B, Liu G, Liu H et al.. Cloning, expression, and antigenicity of 14 proteins from Campylobacter jejuni. Foodborne pathogens and disease 2012. link 51 Persson S, Petersen HM, Jespersgaard C, Olsen KE. Real-time TaqMan polymerase chain reaction-based genus-identification and pyrosequencing-based species identification of Campylobacter jejuni, C. coli, C. lari, C. upsaliensis, and C. fetus directly on stool samples. Diagnostic microbiology and infectious disease 2012. link 52 Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, Norman J et al.. Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. The Journal of infectious diseases 2010. link 53 Matsumoto Y, Kobata T, Odaka M, Furukawa K, Hirata K, Yuki N. BAFF aids generation of IgG anti-ganglioside antibodies in response to Campylobacter jejuni lipo-oligosaccharide. Journal of neuroimmunology 2010. link 54 Qian H, Pang E, Chang J, Toh SL, Ng FK, Tan AL et al.. Monoclonal antibody binding to the major outer membrane protein of Campylobacter coli. Journal of immunological methods 2008. link 55 Harada RM, Campbell S, Li QX. Pseudoxanthomonas kalamensis sp. nov., a novel gammaproteobacterium isolated from Johnston Atoll, North Pacific Ocean. International journal of systematic and evolutionary microbiology 2006. link 56 Murinda SE, Nguyen LT, Oliver SP. Problems in isolation of Campylobacter jejuni from frozen-stored raw milk and bovine fecal samples: genetic confirmation using multiplex PCR. Foodborne pathogens and disease 2004. link 57 Sails AD, Fox AJ, Bolton FJ, Wareing DR, Greenway DL, Borrow R. Development of a PCR ELISA assay for the identification of Campylobacter jejuni and Campylobacter coli. Molecular and cellular probes 2001. link 58 Hoorfar J, Nielsen EM, Stryhn H, Andersen S. Evaluation of two automated enzyme-immunoassays for detection of thermophilic campylobacters in faecal samples from cattle and swine. Journal of microbiological methods 1999. link00080-9) 59 Gomi K, Brooks B, Blais B, Garcia M, Yamazaki H. Immunological detection of lipopolysaccharide antigens of thermophilic campylobacters captured on polymyxin-coated polyester cloth. Immunological investigations 1996. link 60 Chandan V, Fraser AD, Brooks BW, Yamazaki H. Simple extraction of Campylobacter lipopolysaccharide and protein antigens and production of their antibodies in egg yolk. International journal of food microbiology 1994. link90141-4) 61 Griffiths PL, Moreno GS, Park RW. Differentiation between thermophilic Campylobacter species by species-specific antibodies. The Journal of applied bacteriology 1992. link 62 Myszewski MA, Stern NJ. Influence of Campylobacter jejuni cecal colonization on immunoglobulin response in chickens. Avian diseases 1990. link 63 Perez-Perez GI, Cohn DL, Guerrant RL, Patton CM, Reller LB, Blaser MJ. Clinical and immunologic significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the USA. The Journal of infectious diseases 1989. link 64 Kirimat M, Georges-Courbot MC, Georges AJ, Martin PM. Antibodies to Campylobacter flagellin recognize epitopes common to phase 1 and phase 2 flagella. Research in microbiology 1989. link90196-4) 65 Newton CM, Newell DG, Wood M, Baskerville M. Campylobacter infection in a closed dog breeding colony. The Veterinary record 1988. link 66 Kohno A, Terao K, Takasaka M, Honjo S. The serodiagnosis of Campylobacter infection in infant cynomolgus monkeys (Macaca fascicularis) 2 to 18 weeks old by enzyme-linked immunosorbent assay. Laboratory animal science 1988. link 67 Taylor DE, Chang N. Immunoblot and enzyme-linked immunosorbent assays of Campylobacter major outer-membrane protein and application to the differentiation of Campylobacter species. Molecular and cellular probes 1987. link90038-7) 68 Melby K. Antibody response in patients infected with Campylobacter jejuni/coli assayed with a complement fixation test and a DIGELISA method. NIPH annals 1987. link 69 Rautelin H, Kosunen TU. Single and multiple acid extract antigens in Campylobacter serology. Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology 1987. link 70 Blaser MJ, Taylor DN, Echeverria P. Immune response to Campylobacter jejuni in a rural community in Thailand. The Journal of infectious diseases 1986. link 71 McCardell BA, Madden JM, Stanfield JT. Effect of iron concentration on toxin production in Campylobacter jejuni and Campylobacter coli. Canadian journal of microbiology 1986. link 72 Oosterom J, den Uyl CH, Bänffer JR, Lauwers S, Huisman J, Busschbach AE et al.. Evaluation of an enzyme-linked immunosorbent assay (ELISA) for the detection of Campylobacter jejuni antibodies, and comparison with a complement fixation test (CFT). Antonie van Leeuwenhoek 1985. link 73 Naess V, Hofstad T. Antigenicity of lipopolysaccharides from Campylobacter jejuni and Campylobacter coli in passive haemagglutination tests and enzyme-linked immunosorbent assays. Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology 1985. link 74 McMillan A, McNeillage GJ, Watson KC. The prevalence of antibodies reactive with Campylobacter jejuni in the serum of homosexual men. The Journal of infection 1984. link94550-x)

Original source

[1]
Antibiotic Resistance of Campylobacter Species Isolated From Foods, Animals and Humans in Iran Through One Health Approach: A Systematic Review and Meta-Analysis. — Salmani F, Mohamadi S, Tasara T, Ansarifar E, Sadighara P, Zeinali T Veterinary medicine and science (2026)
[2]
Free-range versus conventional: A comparison of microbial composition and Campylobacter contamination in broiler carcasses after chilling. — Hautefeuille S, Guillou S, Bouju-Albert A, Misery B, Laroche B, Haddad N et al. Poultry science (2026)
[3]
Disarming Campylobacter hepaticus - the in vitro and in vivo efficacy of natural antimicrobials as anti-virulence proxies. — Imbrea AM, Balta I, Morariu S, Stef L, Pet I, Crista CL et al. Poultry science (2026)
[4]
Rapid and simultaneous detection of Campylobacter spp. and Salmonella spp. in chicken samples by duplex loop-mediated isothermal amplification coupled with a lateral flow biosensor assay. — Sridapan T, Tangkawsakul W, Janvilisri T, Luangtongkum T, Kiatpathomchai W, Chankhamhaengdecha S PloS one (2021)
[5]
Presence of Campylobacterjejuni and C. coli in Dogs under Training for Animal-Assisted Therapies. — Santaniello A, Varriale L, Dipineto L, Borrelli L, Pace A, Fioretti A et al. International journal of environmental research and public health (2021)
[6]
Campylobacter culture fails to correctly detect Campylobacter in 30% of positive patient stool specimens compared to non-cultural methods. — Buss JE, Cresse M, Doyle S, Buchan BW, Craft DW, Young S European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2019)
[7]
C-Type Lectin Receptor (CLR)-Fc Fusion Proteins As Tools to Screen for Novel CLR/Bacteria Interactions: An Exemplary Study on Preselected Campylobacter jejuni Isolates. — Mayer S, Moeller R, Monteiro JT, Ellrott K, Josenhans C, Lepenies B Frontiers in immunology (2018)
[8]
Evaluation of the Diagnostic Accuracy of Two Immunochromatographic Tests Detecting Campylobacter in Stools and Their Role in Campylobacter Infection Diagnosis. — Bessède E, Asselineau J, Perez P, Valdenaire G, Richer O, Lehours P et al. Journal of clinical microbiology (2018)
[9]
Promising new vaccine candidates against Campylobacter in broilers. — Meunier M, Guyard-Nicodème M, Vigouroux E, Poezevara T, Beven V, Quesne S et al. PloS one (2017)
[10]
Evaluation of detection methods for Campylobacter infections among under-fives in Mwanza City, Tanzania. — Mushi MF, Paterno L, Tappe D, Deogratius AP, Seni J, Moremi N et al. The Pan African medical journal (2014)
[11]
Differences in carbon source utilisation distinguish Campylobacter jejuni from Campylobacter coli. — Wagley S, Newcombe J, Laing E, Yusuf E, Sambles CM, Studholme DJ et al. BMC microbiology (2014)
[12]
Rapid detection of Campylobacter antigen by enzyme immunoassay leads to increased positivity rates. — Giltner CL, Saeki S, Bobenchik AM, Humphries RM Journal of clinical microbiology (2013)
[13]
Expanded multilocus sequence typing and comparative genomic hybridization of Campylobacter coli isolates from multiple hosts. — Lang P, Lefebure T, Wang W, Pavinski Bitar P, Meinersmann RJ, Kaya K et al. Applied and environmental microbiology (2010)
[14]
Genetic tools for the investigation of Roseobacter clade bacteria. — Piekarski T, Buchholz I, Drepper T, Schobert M, Wagner-Doebler I, Tielen P et al. BMC microbiology (2009)
[15]
Double-staining method for differentiation of morphological changes and membrane integrity of Campylobacter coli cells. — Alonso JL, Mascellaro S, Moreno Y, Ferrús MA, Hernández J Applied and environmental microbiology (2002)
[16]
Prevalence, antigenic specificity, and bactericidal activity of poultry anti-Campylobacter maternal antibodies. — Sahin O, Zhang Q, Meitzler JC, Harr BS, Morishita TY, Mohan R Applied and environmental microbiology (2001)
[17]
Evaluation of the Alexon-trend ProSpecT Campylobacter microplate assay. — Tolcin R, LaSalvia MM, Kirkley BA, Vetter EA, Cockerill FR, Procop GW Journal of clinical microbiology (2000)
[18]
Evaluation of antibodies reactive with Campylobacter jejuni in Egyptian diarrhea patients. — Ismail TF, Wasfy MO, Oyofo BA, Mansour MM, El-Berry HM, Churilla AM et al. Clinical and diagnostic laboratory immunology (1997)
[19]
Development of a rapid and specific colony-lift immunoassay for detection and enumeration of Campylobacter jejuni, C. coli, and C. lari. — Rice BE, Lamichhane C, Joseph SW, Rollins DM Clinical and diagnostic laboratory immunology (1996)
[20]
Immunoglobulin A antibodies directed against Campylobacter jejuni flagellin present in breast-milk. — Nachamkin I, Fischer SH, Yang XH, Benitez O, Cravioto A Epidemiology and infection (1994)
[21]
Structural and antigenic characteristics of Campylobacter coli FlaA flagellin. — Power ME, Guerry P, McCubbin WD, Kay CM, Trust TJ Journal of bacteriology (1994)
[22]
Enterotoxin production and serogroups of Campylobacter jejuni and Campylobacter coli from patients with diarrhea and from healthy laying hens. — Lindblom GB, Kaijser B, Sjögren E Journal of clinical microbiology (1989)
[23]
Pathogenesis of Campylobacter spp. in athymic and euthymic germfree mice. — Yrios JW, Balish E Infection and immunity (1986)
[24]
Lipopolysaccharide structures in Enterobacteriaceae, Pseudomonas aeruginosa, and Vibrio cholerae are immunologically related to Campylobacter spp. — Perez-Perez GI, Hopkins JA, Blaser MJ Infection and immunity (1986)
[25]
Adaption of ELISA for the detection of Campylobacter antibodies and its application in seroepidemiological studies in sheep and cattle herds. — Gröhn K, Genigeorgis C Acta veterinaria Scandinavica (1985)
[26]
Detection of campylobacter by immunofluorescence in stools and rectal biopsies of patients with diarrhoea. — Price AB, Dolby JM, Dunscombe PR, Stirling J Journal of clinical pathology (1984)
[27]
Analysis of Campylobacter jejuni antigens with monoclonal antibodies. — Kosunen TU, Bång BE, Hurme M Journal of clinical microbiology (1984)
[28]
An acid extract as a common antigen in Campylobacter coli and Campylobacter jejuni strains. — Rautelin H, Kosunen TU Journal of clinical microbiology (1983)
[29]
Valorization of agricultural waste via pyrolysis: predictive design of biochars for antibiotic removal by linking temperature to DOM/ROS pathways. — Zhou C, Fang H, Fan C, Song J, Azeem M, Li H et al. Bioresource technology (2026)
[30]
Broad-host-range bacteriophages CBP1 and CBP2 with dual-species activity against Campylobacter jejuni and Campylobacter coli. — Ahn E, Kim J, Kim J, Hur JI, Ryu S, Jeon B International journal of food microbiology (2026)
[31]
The effectiveness of slurry ice for reducing Campylobacter on free-range poultry carcasses. — Calvo-Fernandez C, Lassen B, Jensen AN, Takeuchi-Storm N International journal of food microbiology (2026)
[32]
Prevalence and characterization of antibiotic susceptibility of Campylobacter strains from the chicken meat industry in Bosnia and Herzegovina. — Hrustemović E Journal of the science of food and agriculture (2026)
[33]
Rapid determination of viable but non-culturable Campylobacter jejuni in food products by loop-mediated isothermal amplification coupling propidium monoazide treatment. — Petersen M, Ma L, Lu X International journal of food microbiology (2021)
[34]
Evaluation of a commercial loop-mediated isothermal amplification assay, 3MTM Molecular Detection Assay 2 - Campylobacter, for the detection of Campylobacter from poultry matrices. — Rajagopal R, Barnes CA, David JM, Goseland J, Goseland J British poultry science (2021)
[35]
A loop-mediated isothermal amplification (LAMP) assay for the consensus detection of human pathogenic Campylobacter species. — Babu US, Harrison LM, Mammel MK, Bigley EC, Hiett KL, Balan KV Journal of microbiological methods (2020)
[36]
E. coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro. — Mawad A, Helmy YA, Shalkami AG, Kathayat D, Rajashekara G Applied microbiology and biotechnology (2018)
[37]
Immune response-eliciting exposure to Campylobacter vastly exceeds the incidence of clinically overt campylobacteriosis but is associated with similar risk factors: A nationwide serosurvey in the Netherlands. — Monge S, Teunis P, Friesema I, Franz E, Ang W, van Pelt W et al. The Journal of infection (2018)
[38]
Epidemiology of antimicrobial resistant Campylobacter spp. isolated from retail meats in Canada. — Narvaez-Bravo C, Taboada EN, Mutschall SK, Aslam M International journal of food microbiology (2017)
[39]
Development of a monoclonal antibody-based colony blot immunoassay for detection of thermotolerant Campylobacter species. — Huang H, Phipps-Todd B, McMahon T, Elmgren CL, Lutze-Wallace C, Todd ZA et al. Journal of microbiological methods (2016)
[40]
Detection of Campylobacter in human and animal field samples in Cambodia. — Osbjer K, Tano E, Chhayheng L, Mac-Kwashie AO, Fernström LL, Ellström P et al. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica (2016)
[41]
Ex vivo proteomics of Campylobacter jejuni 81-176 reveal that FabG affects fatty acid composition to alter bacterial growth fitness in the chicken gut. — Asakura H, Kawamoto K, Murakami S, Tachibana M, Kurazono H, Makino S et al. Research in microbiology (2016)
[42]
Sensitive and rapid detection of campylobacter species from stools of children with diarrhea in Japan by the loop-mediated isothermal amplification method. — Ushijima H, Nishimura S, Thongprachum A, Shimizu-Onda Y, Tran DN, Pham NT et al. Japanese journal of infectious diseases (2014)
[43]
A comparative study of conventional and molecular techniques in diagnosis of campylobacter gastroenteritis in children. — Ghosh R, Uppal B, Aggarwal P, Chakravarti A, Jha AK, Dubey AP Annals of clinical and laboratory science (2014)
[44]
Isolation of Campylobacter from human stool samples. — Salim SM, Mandal J, Parija SC Indian journal of medical microbiology (2014)
[45]
Cow's milk with active immunoglobulins against Campylobacter jejuni: effects of temperature on immunoglobulin activity. — Riera F, Alvarez A, Espi A, Prieto M, de la Roza B, Vicente F Journal of the science of food and agriculture (2014)
[46]
Review of current methodologies to isolate and identify Campylobacter spp. from foods. — Gharst G, Oyarzabal OA, Hussain SK Journal of microbiological methods (2013)
[47]
Antimicrobial resistance in campylobacter: susceptibility testing methods and resistance trends. — Ge B, Wang F, Sjölund-Karlsson M, McDermott PF Journal of microbiological methods (2013)
[48]
Assessment of the prevalence and diversity of emergent campylobacteria in human stool samples using a combination of traditional and molecular methods. — Collado L, Gutiérrez M, González M, Fernández H Diagnostic microbiology and infectious disease (2013)
[49]
Detection of antibodies to Campylobacter in humans using enzyme-linked immunosorbent assays: a review of the literature. — Kuhn KG, Falkenhorst G, Ceper T, Dalby T, Ethelberg S, Mølbak K et al. Diagnostic microbiology and infectious disease (2012)
[50]
Cloning, expression, and antigenicity of 14 proteins from Campylobacter jejuni. — Zhang M, Meng F, Cao F, Qiao B, Liu G, Liu H et al. Foodborne pathogens and disease (2012)
[51]
Real-time TaqMan polymerase chain reaction-based genus-identification and pyrosequencing-based species identification of Campylobacter jejuni, C. coli, C. lari, C. upsaliensis, and C. fetus directly on stool samples. — Persson S, Petersen HM, Jespersgaard C, Olsen KE Diagnostic microbiology and infectious disease (2012)
[52]
Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. — Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, Norman J et al. The Journal of infectious diseases (2010)
[53]
BAFF aids generation of IgG anti-ganglioside antibodies in response to Campylobacter jejuni lipo-oligosaccharide. — Matsumoto Y, Kobata T, Odaka M, Furukawa K, Hirata K, Yuki N Journal of neuroimmunology (2010)
[54]
Monoclonal antibody binding to the major outer membrane protein of Campylobacter coli. — Qian H, Pang E, Chang J, Toh SL, Ng FK, Tan AL et al. Journal of immunological methods (2008)
[55]
Pseudoxanthomonas kalamensis sp. nov., a novel gammaproteobacterium isolated from Johnston Atoll, North Pacific Ocean. — Harada RM, Campbell S, Li QX International journal of systematic and evolutionary microbiology (2006)
[56]
Problems in isolation of Campylobacter jejuni from frozen-stored raw milk and bovine fecal samples: genetic confirmation using multiplex PCR. — Murinda SE, Nguyen LT, Oliver SP Foodborne pathogens and disease (2004)
[57]
Development of a PCR ELISA assay for the identification of Campylobacter jejuni and Campylobacter coli. — Sails AD, Fox AJ, Bolton FJ, Wareing DR, Greenway DL, Borrow R Molecular and cellular probes (2001)
[58]
Evaluation of two automated enzyme-immunoassays for detection of thermophilic campylobacters in faecal samples from cattle and swine. — Hoorfar J, Nielsen EM, Stryhn H, Andersen S Journal of microbiological methods (1999)
[59]
Immunological detection of lipopolysaccharide antigens of thermophilic campylobacters captured on polymyxin-coated polyester cloth. — Gomi K, Brooks B, Blais B, Garcia M, Yamazaki H Immunological investigations (1996)
[60]
Simple extraction of Campylobacter lipopolysaccharide and protein antigens and production of their antibodies in egg yolk. — Chandan V, Fraser AD, Brooks BW, Yamazaki H International journal of food microbiology (1994)
[61]
Differentiation between thermophilic Campylobacter species by species-specific antibodies. — Griffiths PL, Moreno GS, Park RW The Journal of applied bacteriology (1992)
[62]
Influence of Campylobacter jejuni cecal colonization on immunoglobulin response in chickens. — Myszewski MA, Stern NJ Avian diseases (1990)
[63]
Clinical and immunologic significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the USA. — Perez-Perez GI, Cohn DL, Guerrant RL, Patton CM, Reller LB, Blaser MJ The Journal of infectious diseases (1989)
[64]
Antibodies to Campylobacter flagellin recognize epitopes common to phase 1 and phase 2 flagella. — Kirimat M, Georges-Courbot MC, Georges AJ, Martin PM Research in microbiology (1989)
[65]
Campylobacter infection in a closed dog breeding colony. — Newton CM, Newell DG, Wood M, Baskerville M The Veterinary record (1988)
[66]
The serodiagnosis of Campylobacter infection in infant cynomolgus monkeys (Macaca fascicularis) 2 to 18 weeks old by enzyme-linked immunosorbent assay. — Kohno A, Terao K, Takasaka M, Honjo S Laboratory animal science (1988)
[67]
Immunoblot and enzyme-linked immunosorbent assays of Campylobacter major outer-membrane protein and application to the differentiation of Campylobacter species. — Taylor DE, Chang N Molecular and cellular probes (1987)
[68]
Antibody response in patients infected with Campylobacter jejuni/coli assayed with a complement fixation test and a DIGELISA method. — Melby K NIPH annals (1987)
[69]
Single and multiple acid extract antigens in Campylobacter serology. — Rautelin H, Kosunen TU Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology (1987)
[70]
Immune response to Campylobacter jejuni in a rural community in Thailand. — Blaser MJ, Taylor DN, Echeverria P The Journal of infectious diseases (1986)
[71]
Effect of iron concentration on toxin production in Campylobacter jejuni and Campylobacter coli. — McCardell BA, Madden JM, Stanfield JT Canadian journal of microbiology (1986)
[72]
Evaluation of an enzyme-linked immunosorbent assay (ELISA) for the detection of Campylobacter jejuni antibodies, and comparison with a complement fixation test (CFT). — Oosterom J, den Uyl CH, Bänffer JR, Lauwers S, Huisman J, Busschbach AE et al. Antonie van Leeuwenhoek (1985)
[73]
Antigenicity of lipopolysaccharides from Campylobacter jejuni and Campylobacter coli in passive haemagglutination tests and enzyme-linked immunosorbent assays. — Naess V, Hofstad T Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology (1985)
[74]
The prevalence of antibodies reactive with Campylobacter jejuni in the serum of homosexual men. — McMillan A, McNeillage GJ, Watson KC The Journal of infection (1984)

Share:Twitter Reddit LinkedIn